<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>News &amp; Insights</title>
    <link>https://axiobiopharma.com/news</link>
    <description />
    <language>en-us</language>
    <pubDate>Tue, 21 Apr 2026 21:48:42 GMT</pubDate>
    <dc:date>2026-04-21T21:48:42Z</dc:date>
    <dc:language>en-us</dc:language>
    <item>
      <title>Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin</title>
      <link>https://axiobiopharma.com/news/axio-biopharma-named-icp-round-1-awardee-advancing-ai-ready-biologics-manufacturing-in-wisconsin</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://axiobiopharma.com/news/axio-biopharma-named-icp-round-1-awardee-advancing-ai-ready-biologics-manufacturing-in-wisconsin" title="" class="hs-featured-image-link"&gt; &lt;img src="https://axiobiopharma.com/hubfs/Forward+BIOLABS_Clear+background.webp" alt="Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;&lt;strong&gt;Madison, WI (February 3, 2026)&lt;/strong&gt; — Axio BioPharma, an AI-ready biologics contract development and manufacturing organization (CDMO), today announced it has been selected as a Round 1 awardee of the Innovation to Commercialization Pipeline (ICP) program, led by Forward BIOLABS in partnership with BioForward Wisconsin.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://axiobiopharma.com/news/axio-biopharma-named-icp-round-1-awardee-advancing-ai-ready-biologics-manufacturing-in-wisconsin" title="" class="hs-featured-image-link"&gt; &lt;img src="https://axiobiopharma.com/hubfs/Forward+BIOLABS_Clear+background.webp" alt="Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;&lt;strong&gt;Madison, WI (February 3, 2026)&lt;/strong&gt; — Axio BioPharma, an AI-ready biologics contract development and manufacturing organization (CDMO), today announced it has been selected as a Round 1 awardee of the Innovation to Commercialization Pipeline (ICP) program, led by Forward BIOLABS in partnership with BioForward Wisconsin.&lt;/p&gt;  
&lt;img src="https://track.hubspot.com/__ptq.gif?a=46296048&amp;amp;k=14&amp;amp;r=https%3A%2F%2Faxiobiopharma.com%2Fnews%2Faxio-biopharma-named-icp-round-1-awardee-advancing-ai-ready-biologics-manufacturing-in-wisconsin&amp;amp;bu=https%253A%252F%252Faxiobiopharma.com%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Wisconsin Biohealth</category>
      <category>Forward BIOLABS</category>
      <category>AI in Biomanufacturing</category>
      <pubDate>Tue, 03 Feb 2026 05:00:00 GMT</pubDate>
      <guid>https://axiobiopharma.com/news/axio-biopharma-named-icp-round-1-awardee-advancing-ai-ready-biologics-manufacturing-in-wisconsin</guid>
      <dc:date>2026-02-03T05:00:00Z</dc:date>
      <dc:creator>Axio BioPharma</dc:creator>
    </item>
    <item>
      <title>Axio BioPharma Expands Advisory Board with Leaders in Biologics Development and Manufacturing</title>
      <link>https://axiobiopharma.com/news/axio-biopharma-expands-advisory-board-with-leaders-in-biologics-development-and-manufacturing</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://axiobiopharma.com/news/axio-biopharma-expands-advisory-board-with-leaders-in-biologics-development-and-manufacturing" title="" class="hs-featured-image-link"&gt; &lt;img src="https://axiobiopharma.com/hubfs/ABP-Logo-Vertical-Color-RGB.jpg" alt="Axio BioPharma Expands Advisory Board with Leaders in Biologics Development and Manufacturing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;&lt;strong&gt;MADISON, Wis., June 16, 2025&lt;/strong&gt; -- Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, today announced the continued expansion of its advisory board with the recent addition of Patrick Haffey. He joins existing advisors Dr. Greg Bleck and Dr. Graham Brearley, forming a deeply experienced group of leaders in biologics research, development, and operations.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://axiobiopharma.com/news/axio-biopharma-expands-advisory-board-with-leaders-in-biologics-development-and-manufacturing" title="" class="hs-featured-image-link"&gt; &lt;img src="https://axiobiopharma.com/hubfs/ABP-Logo-Vertical-Color-RGB.jpg" alt="Axio BioPharma Expands Advisory Board with Leaders in Biologics Development and Manufacturing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;&lt;strong&gt;MADISON, Wis., June 16, 2025&lt;/strong&gt; -- Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, today announced the continued expansion of its advisory board with the recent addition of Patrick Haffey. He joins existing advisors Dr. Greg Bleck and Dr. Graham Brearley, forming a deeply experienced group of leaders in biologics research, development, and operations.&lt;/p&gt;  
&lt;img src="https://track.hubspot.com/__ptq.gif?a=46296048&amp;amp;k=14&amp;amp;r=https%3A%2F%2Faxiobiopharma.com%2Fnews%2Faxio-biopharma-expands-advisory-board-with-leaders-in-biologics-development-and-manufacturing&amp;amp;bu=https%253A%252F%252Faxiobiopharma.com%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Mon, 16 Jun 2025 04:00:00 GMT</pubDate>
      <guid>https://axiobiopharma.com/news/axio-biopharma-expands-advisory-board-with-leaders-in-biologics-development-and-manufacturing</guid>
      <dc:date>2025-06-16T04:00:00Z</dc:date>
      <dc:creator>Axio BioPharma</dc:creator>
    </item>
  </channel>
</rss>
